Evidence map›Paper›PMID 31220471›Full record

Trial reportThe Journal of allergy and clinical immunology2019

Reference intervals for lymphocyte subsets in preterm and term neonates without immune defects.

George S Amatuni, Stanley Sciortino, Robert J Currier, Stanley J Naides, Joseph A Church, Jennifer M Puck

Open access · greenAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in The Journal of allergy and clinical immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. First Year of TREC-Based National SCID Screening in Sweden.International journal of neonatal screening · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. SCID newborn screening: What we've learned.The Journal of allergy and clinical immunology · 2021
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

George S AmatuniDepartment of Pediatrics, University of California San Francisco School of Medicine, San Francisco, Calif; Stem Cell Institute, Department of Cell Biology, Einstein College of Medicine, Bronx, NY.
Stanley SciortinoGenetic Disease Screening Program, California Department of Public Health, Richmond, Calif.
Robert J CurrierDepartment of Pediatrics, University of California San Francisco School of Medicine, San Francisco, Calif.
Stanley J NaidesImmunology Department, Quest Diagnostics Nichols Institute, San Juan Capistrano, Calif.
Joseph A ChurchDepartment of Pediatrics, University of Southern California Keck School of Medicine, Los Angeles, Calif; Children's Hospital Los Angeles, Los Angeles, Calif.
Jennifer M PuckDepartment of Pediatrics, University of California San Francisco School of Medicine, San Francisco, Calif; Institute for Human Genetics, University of California San Francisco, San Francisco, Calif; Smith Cardiovascular Research Institute, University of California San Francisco, San Francisco, Calif; Benioff Children's Hospital, University of California San Francisco, San Francisco, Calif. Electronic address: Jennifer.Puck@ucsf.edu.
University of California, San Francisco · USCalifornia Department of Public Health · USQuest Diagnostics (United States) · USUCSF Benioff Children's Hospital · USUniversity of Southern California · US

Funding

Training of Clinical Investigators in Primary Immune DeficienciesU54AI082973 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MALECH, HARRY · 2009 to 2023
$23.3M
Newborn Screening for T-Cell Disorders: Spectrum and OutcomesR01AI105776 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BRENNER, STEVEN E, CHURCH, JOSEPH · 2013 to 2016
$2.4M
Primary Immune Deficiency Treatment Consortium Annual Scientific MeetingR13AI094943 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PUCK, JENNIFER M. · 2011 to 2025
$239k
Newborn Screening for SCID in a High-Risk PopulationR03HD060311 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PUCK, JENNIFER M. · 2008 to 2009
$155k
NIAID NIH HHS R01 AI105776NIAID NIH HHS R13 AI094943NIAID NIH HHS U54 AI082973NICHD NIH HHS R03 HD060311
6 · The paper itself

Abstract

backgroundIn 6.5 years of newborn screening for severe combined immunodeficiency in California, 3,252,156 infants had DNA from dried blood spots (DBSs) assayed for T-cell receptor excision circles. Infants with T-cell receptor excision circle values of less than a designated cutoff on a single DBS, 2 DBS samples with insufficient PCR amplification, or known genetic risk of immunodeficiency had peripheral blood complete blood counts and lymphocyte subsets assayed in a single flow cytometry laboratory. Cases in which immune defects were ruled out were available for analysis.

objectiveWe sought to determine reference intervals for lymphocyte subsets in racially/ethnically diverse preterm and term newborns who proved to be unaffected by any T-lymphopenic immune disorder.

methodsEffective gestational age (GA) was defined as GA at birth plus postnatal age at the time of sample collection. After determining exclusion criteria, we analyzed demographic and clinical information, complete and differential white blood cell counts, and lymphocyte subsets for 301 infants, with serial measurements for 33 infants. Lymphocyte subset measurements included total T cells, helper and cytotoxic T-cell subsets, naive and memory phenotype of each T-cell subset, B cells, and natural killer cells.

resultsReference intervals were generated for absolute numbers and lymphocyte subsets from infants with effective GAs of 22 to 52 weeks. Sex and ethnicity were not significant determinants of lymphocyte subset counts in this population. Lymphocyte counts increased postnatally.

conclusionThis study provides a baseline for interpreting comprehensive lymphocyte data in preterm and term infants, aiding clinicians to determine which newborns require further evaluations for immunodeficiency.

Indexed as

B-LymphocytesCD8-Positive T-LymphocytesDried Blood Spot TestingFemaleGestational AgeHumansInfant, NewbornInfant, PrematureLymphocyte CountMalePolymerase Chain ReactionReceptors, Antigen, T-CellT-Lymphocytes, Helper-InducerReceptors, Antigen, T-CellFlow cytometrymemory T cellnaive T cellneonatal immunitynewborn screeningpreterm birthreference range/reference intervalsevere combined immunodeficiencyT-cell receptor excision circleT-cell subsets

Identifiers

PMID31220471
PMCPMC6900445
OpenAlexW2952267457

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.